Overview of naphthalimide analogs as anticancer agents

Current Medicinal Chemistry

Volumn 16, Issue 36, 2009, Pages 4797-4813

  Lv, Min ^a   Xu, Hui ^a  

^a NORTHWEST A F UNIVERSITY   (China)

Author keywords

Anticancer; Bisnaphthalimide; Chemotherapy; Mechanism of action; Mononaphthalimide; Naphthalimide; Structure activity relationship; Synthesis

Indexed keywords

2 SUBSTITUTED PHENYLNAPHTHOL[2,1]THIAZOLE 5 CARBOXAMIDE DERIVATIVE; AMONAFIDE; ANTINEOPLASTIC AGENT; BISNAFIDE; BISNAPHTHALAMIDE DERIVATIVE; ELINAFIDE; MITONAFIDE; MONONAPHTHALAMIDE DERIVATIVE; NAPHTHALAMIDE POLYAMINE CONJUGATE; NAPHTHALAMIDE THIAZOLE DERIVATIVE; NAPHTHALIMIDE DERIVATIVE; PYRROLO[2,1][1,4]BENZODIAZEPINE NAPHTHALAMIDE; PYRROLOBENZODIAZEPINE NAPHTHALAMIDE CONJUGATE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BINDING AFFINITY; CANCER CELL CULTURE; DNA BINDING; DRUG ACTIVITY; DRUG BINDING; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; HUMANS; NAPHTHALIMIDES; NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 71949096417     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709789909576     Document Type: Review

References (58)

1. Rawat, D.S. Recent advances in cancer chemotherapy-part I. Anti-Cancer Agents Med. Chem., 2008, 8, 122.
2. Boyle, P.; Levin, B. World Cancer Report 2008, IARC Nonserial publication: IARC, 2008.
3. Muth, M.; Hoerr, V.; Glaser, M.; Ponte-Sucre, A.; Moll, H.; Stich, A.; Holzgrabe, U. Antitrypanosomal activity of quaternary naphthalimide derivatives. Bioorg. Med. Chem. Lett., 2007, 17, 1590-1593 (Pubitemid 46274342)
4. Andricopulo, A.D.; Muller, L.A.; Cechinel, V.; Cani, G.S.; Roos, J.F.; Correa, R.; Santos, A.R.S.; Nunes, R.J.; Yunes, R.A. Analgesic activity of cyclic imides: 1,8-naphthalimide and 1,4,5,8-naphthalenediimide derivatives. FARMACO, 2000, 55, 319-321
5. Grabchev, I.; Staneva, D.; Betcheva, R. Sensor activity, photodegradation and photostabilisation of a PAMAM dendrimer comprising 1,8-naphthalimide functional groups in its periphery. Polym. Degrad. Stabil., 2006, 91, 2257-2264 (Pubitemid 43963181)
6. Xu, Y.F.; Qian, X.H.; Yao, W.; Mao, P.; Cui, J.N. Novel naphthalimide hydroperoxide photonucleases: the role of thiocyclicfused area and the difference in spectra, photochemistry and photobiological activity. Bioorg. Med. Chem., 2003, 11, 5427-5433
7. Kowalski, P.; Kowalska, T.; Bojarski, A.J.; Duszynska, B. Synthesis and biological properties of 1,8-naphthalimidebutylamines. Serotonin 5-HT1A and 5-HT7 binding data and pass-assisted search. J. Heterocyclic Chem., 2007, 44, 889-893
8. De Souza, M.M.; Correa, R.; Cechinel, V.; Grabchev, I.; Bojinov, V. 4-Nitro-1,8-naphthalimides exhibit antinociceptive properties. Pharmazie, 2002, 57, 430-431
9. Langlois, M.; Soulier, J.L.; Rampillon, V.; Gallais, C.; Bremont, B.; Shen, S.; Yang, D.; Giudice, A.; Sureau, F. Synthesis of quinazoline-2,4-dione and naphthalimide derivatives as new 5-HT3 receptor antagonists. Eur. J. Med. Chem., 1994, 29, 925-940
10. Langlois, M.; Soulier, J.L.; Bremont, B.; Shen, S.; Rampillon, V.; Giudice, A. Derivatives of naphthalimide-new potent conformationally restricted antagonists of 5-HT3 receptors. Bioorg. Med. Chem. Lett., 1992, 2, 691-694
11. Kawai, K.; Kawabata, K.; Tojo, S.; Majima,T. Synthesis of ODNs containing 4-methylamino-1,8-naphthalimide as a fluorescence probe in DNA. Bioorg. Med. Chem. Lett., 2002, 12, 2363-2366
12. Brana, M.F.; Castellano, J.M.; Moran, M.; Devega, M.J.P.; Perron, D.; Conlon, D.; Bousquet, P.F.; Romerdahl, C.A.; Robinson, S.P. Bis-naphthalimides. 3. Synthesis and antitumor activity of N,N′-bis[2-(1,8-naphthalimido)- ethyl]alkanediamines. Anti-Cancer Drug Design, 1996, 11, 297-309.
13. Brana, M.F.; Castellano, J.M.; Moran, M.; Devega, M.J.P.; Qian, X.D.; Romerdahl, C.A.; Keilhauer, G. Bis-naphthalimides. 2. Synthesis and biological activity of 5,6-acenaphthalimidoalkyl-1,8-naphthalimidoalkyl amines. Eur. J. Med. Chem., 1995, 30, 235-239
14. Gupta, R.; Liu, J.X.; Xie, G.J.; Lown, J.W. Novel DNA-directed alkylating agents consisting of naphthalimide, nitrogen mustard and lexitropsin moieties: synthesis, DNA sequence specificity and biological evaluation. Anti-Cancer Drug Design, 1996, 11, 581-596
15. Costanza, M.E.; Berry, D.; Henderson, I.C.; Ratain, M.J.; Wu, K.; Shapiro, C.; Duggan, D.; kalra, J.; Berkowitz, I.; Lyss, A.P. Amonafide: an active agent in the treatment of previously untreated advanced breast cancer-a cancer and leukemia group B study (CALGB 8642). Clin. Cancer Res., 1995, 1, 699-704.
16. Kreis, W.; Chan, K.; Budman, D.R.; Allen, S.L.; Fusco, D.; Mittelman, A.; Hock, K.; Akerman, S.; Calabro, A.; Puccio, C.; Spigelman, M. Clinical pharmacokinetics of amonafide (NSC 308847) in 62 patients. Cancer Invest., 1996, 14, 320-327 (Pubitemid 26249169)
17. Thompson, J.; Pratt, C.B.; Stewart, C.F.; Avery, L.; Bowman, L.; Zamboni, W.C.; Pappo, A. Phase I study of DMP 840 in pediatric patients with refractory solid tumors. Invest. New Drugs, 1998, 16, 45-49 (Pubitemid 28379415)
18. Bousquet, P.F.; Brana, M.F.; Conlon, D.; Fitzgerald, K.M.; Perron, D.; Cocchiaro, C.; Miller, R.; Moran, M.; George, J.; Qian, X.D.; Keilhauer, G.; Romerdahl, C.A. Preclinical evaluation of LU 79553: a novel bisnaphthalimide with potent antitumor activity. Cancer Res., 1995, 55, 1176-1180
19. Villalona-Calero, M.A.; Eder, J.P.; Toppmeyer, D.L.; Allen, L.F.; Fram, R.; Velagapudi, R.; Myers, M.; Amato, A.; Kagen-Hallet, K.; Razvillas, B.; Kufe, D.W.; Von Hoff, D.D.; Rowinsky, E.K. Phase I and pharmacokinetic study of LU 79553, a DNA intercalating bisnaphthalimide, in patients with solid malignancies. J. Clin. Oncol., 2001, 19, 857-869 (Pubitemid 32119102)
20. Brana, M.F.; Cacho, M.; Ramos, A.; Dominguez, M.T.; Pozuelo, J.M.; Abradelo, C.; Rey-Stolle, M.F.; Yuste, M.; Carrasco, C.; Bailly, C. Synthesis, biological evaluation and DNA binding properties of novel mono and bis naphthalimides. Org. Biomol. Chem., 2003, 1, 648-654
21. Hsiang, Y.H.; Jiang, J.B.; Liu, L.F. Topoisomerase II-mediated DNA cleavage by amonafide and its structural analogs. Mol. Pharmacol., 1989, 36, 371-376
22. Pavlov, V.; Kong Thoo Lin, P.; Rodilla, V. Cytotoxity, DNA binding and localisation of novel bis-naphthalimidopropyl polyamine derivatives. Chem. -Biol. Interact., 2001, 137, 15-24.
23. Nitiss, J.L.; Zhou, J.; Rose, A.; Hsiung, Y.; Gale, K.C.; Osheroff, N. The bis(naphthalimide) DMP-840 causes cytotoxicity by its action against eukaryotic topoisomerase II. Biochemistry, 1998, 37, 3078-3085 (Pubitemid 28145762)
24. Gallego, J.; Reid, B.R. Solution structure and dynamics of a complex between DNA and the antitumor bisnaphthalimide LU-79553: intercalated ring flipping on the millisecond time scale. Biochemistry, 1999, 38, 15104-15115
25. Bailly, C.; Brana, M.; Waring, M.J. Sequence-selective intercalation of antitumor bisnaphthalimides into DNA. Evidence for an approach via the major groove. Eur. J. Biochem., 1996, 240, 195-208. (Pubitemid 26276772)
26. Brana, M.F.; Romas, A. Naphthalimides as anticancer agents: synthesis and biological activity. Curr. Med. Chem. Anti-Cancer Agents, 2001, 1, 237-255
27. Ingrassia, L.; Lefranc, F.; Kiss, R.; Mijatovic, T. Naphthalimides and azonafides as promising anti-cancer agents. Curr. Med. Chem., 2009, 16, 1192-1213
28. Tao, Z.; Qian, X.; Wei, D. 1,8-Naphthalimide hydroperoxides as novel intercalating DNA cleavers. Dyes Pigments, 1996, 31, 245-251 (Pubitemid 126324167)
29. Yao, W.; Qian, X.; Hu, Q. Novel and highly efficient DNA photo-cleavers: hydroperoxides of heterocyclic-fused naphthalimides. Tetrahedron Lett., 2000, 41, 7711-7715
30. Qian, X.; Li, Y.; Xu, Y.; Liu, Y.; Qu, B. Highly-efficient DNA photocleavers with long wavelength absorptions: thio-heterocyclic fused naphthalimides containing aminoalkyl side chains. Bioorg. Med. Chem. Lett., 2004, 14, 2665-2668 (Pubitemid 38515724)
31. Absalon, M.J.; Kozarich, J.W.; Stubbe, J. Sequence-specific double-strand cleavage of DNA by Fe-bleomycin. 1. The detection of sequence-specific double-strand breaks using hairpin oligonucleotides. Biochemistry, 1995, 34, 2065-2075
32. Xu, Y.; Huang, X.; Qian, X.; Yao, W. N-Aroyloxylthioxonaphthalimides as DNA photocleavers of aroyloxyl oxygen radicals: synthesis, evaluation, and substituents' effect. Bioorg. Med. Chem., 2004, 12, 2335-2341 (Pubitemid 38471717)
33. Xu, Y.; Qu, B.; Qian, X.; Li, Y. Five-member thio-heterocyclic fused naphthalimides with aminoalkyl side chains: intercalation and photocleavage to DNA. Bioorg. Med. Chem. Lett., 2005, 15, 1139-1142 (Pubitemid 40458663)
34. Li, Y.; Xu, Y.; Qian, X.; Qu, B. Naphthalimide-thiazoles as novel photonucleases: molecular design, synthesis, and evaluation. Tetrahedron Lett., 2004, 45, 1247-1251 (Pubitemid 38156035)
35. Li, Z.; Yang, Q.; Qian, X. Novel heterocyclic family of phenyl naphthothiazole carboxamides derived from naphthalimides: synthesis, antitumor evaluation, and DNA photocleavage. Bioorg. Med. Chem., 2005, 13, 3149-3155 (Pubitemid 40462118)
36. Christensen, U.B.; Pedersen, E.B. Intercalating nucleic acids containing insertions of 1-O-(1-pyrenylmethyl)glycerol: stabilisation of dsDNA and discrimination of DNA over RNA. Nucleic Acids Res., 2002, 30, 4918-4925
37. Wamberg, M.C.; Walczak, K.; Andersen, L.; Hassan, A.A.; Pedersen, E.B. Intercalating nucleic acids containing insertions of naphthalimide. Helv. Chim. Acta, 2006, 89, 1826-1839
38. Denny, W.A.; Wilson, W.R. The design of selectively activated anti-cancer prodrugs for use in antibody-directed and gene-directed enzyme-prodrug therapies. J. Pharm. Pharmacol., 1998, 50, 387-394
39. Yin, H.; Xu, Y.; Qian, X.; Li, Y.; Liu, J. Novel N-oxide of naphthalimides as prodrug leads against hypoxic solid tumor: synthesis and biological evaluation. Bioorg. Med. Chem. Lett., 2007, 17, 2166-2170
40. Van Quaquebeke, E.; Mahieu, T.; Dumont, P.; Dewelle, J.; Ribaucour, F.; Simon, G.; Sauvage, S.; Gaussin, J.F.; Tuti, J.; Yazidi, M.E.; Van Vynckt, F.; Mijatovic, T.; Lefrance, F.; Darro, F.; Kiss, R. 2,2,2-Trichloro-N-({2-[2- (dimethylamino) ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-5-yl} carbamoyl)acetamide (UNBS3157), a novel nonhematotoxic naphthalimide derivative with potent antitumor activity. J. Med. Chem., 2007, 50, 4122-4134 (Pubitemid 47301744)
41. Yang, Q.; Yang, P.; Qian, X.; Tong, L. Naphthalimide intercalators with chiral amino side chains: effects of chirality on DNA binding, photodamage and antitumor cytotoxicity. Bioorg. Med. Chem. Lett., 2008, 18, 6210-6213
42. Ott, I.; Xu, Y.; Liu, J.; Kokoschka, M.; Harlos, M.; Sheldrick, W.S.; Qian, X. Sulfur-substituted naphthalimides as photoactivatable anticancer agents: DNA interaction, fluorescence imaging, and phototoxic effects in cultured tumor cells. Bioorg. Med. Chem., 2008, 16, 7107-7116
43. Innocenti, F.; Iyer, L.; Ratain, M.J. Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecan. Drug Metab. Dispos., 2001, 29, 596-600.
44. Taningher, M.; Malacarne, D.; Izzotti, A.; Ugolini, D.; Parodi, S. Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat. Res., 1999, 436, 227-261 (Pubitemid 29246091)
45. Felder, T.B.; McLean, M.A.; Vestal, M.L.; Lu, K.; Farquhar, D.; Legha, S.S.; Shah, R.; Newman, R.A. Pharmacokinetics and metabolism of the antitumor drug amonafide (NSC-308847) in humans. Drug Metab. Dispos., 1987, 15, 773-778
46. Norton, J.T.; Witschi, M.A.; Luong, L.; Kawamura, A.; Ghosh, S.; Sharon Stack, M.; Sim, E.; Avram, M.; Michael, J.; Appella, D.H.; Huang, S. Synthesis and anticancer activities of 6-amino amonafide derivatives. Anticancer Drugs, 2008, 19, 23-26
47. Tian, Z.; Xie, S.; Du, Y.; Ma, Y.; Zhao, J.; Gao, W.; Wang, C. Synthesis, cytotoxicity and apoptosis of naphthalimide polyamine conjugates as antitumor agents. Eur. J. Med. Chem., 2009, 44, 393-399
48. Xie, L.; Xu, Y.; Wang, F.; Liu, J.; Qian, X.; Cui, J. Synthesis of new amonafide analogues via coupling reaction and their cytotoxic evaluation and DNA-binding studies. Bioorg. Med. Chem., 2009, 17, 804-810
49. Kaur, J.; Ghosh, N.N.; Chandra, R. Synthesis and antispasmodic activity evaluation of bis-(papaverine) analogues. Chem. Pharm. Bull., 2004, 52, 316-321 (Pubitemid 41685531)
50. Carrasco, C.; Joubert, A.; Tardy, C.; Maestre, N.; Cacho, M.; Brana, M.F.; Bailly, C. DNA sequence recognition by bispyrazinonaphthalimides antitumor agents. Biochemistry, 2003, 42, 11751-11761 (Pubitemid 37243636)
51. Mekapati, S.B.; Denny, W.A.; Kurup, A.; Hansch, C. QSAR of anticancer compounds. Bis(11-oxo-11H-indeno[1,2-b]quinoline-6-carboxamides), bis(phenazine-1-carboxamides), and bis(naphthalimides). Bioorg. Med. Chem., 2001, 9, 2757-2762 (Pubitemid 32904521)
52. Brana, M.F.; Cacho, M.; Garcia, M.A.; de Pascual-Teresa, B.; Ramos, A.; Acero, N.; Llinares, F.; Munoz-Mingarro, D.; Abradelo, C.; Rey-Stolle, M.F.; Yuste, M. Synthesis, antitumor activity, molecular modeling, and DNA binding properties of a new series of imidazonaphthalimides. J. Med. Chem., 2002, 45, 5813-5816
53. Brana, M.F.; Cacho, M.; Garcia, M.A.; de Pascual-Teresa, B.; Ramos, A.; Dominguez, M.T.; Pozuelo, J.M.; Abradelo, C.; Rey-Stolle, M.F.; Yuste, M.; Banez-Coronel, M.; Lacal, J.C. New analogues of amonafide and elinafide, containing aromatic heterocycles: synthesis, antitumor activity, molecular modeling, and DNA binding properties. J. Med. Chem., 2004, 47, 1391-1399
54. Filosa, R.; Peduto, A.; Di Micco, S.; de Caprariis, P.; Festa, M.; Petrella, A.; Capranico, G.; Bifulco, G. Molecular modelling studies, synthesis and biological activity of a series of novel bisnaphthalimides and their development as new DNA topoisomerase II inhibitors. Bioorg. Med. Chem., 2009, 17, 13-24.
55. Kamal, A.; Srinivas, O.; Ramulu, P.; Ramesh, G.; Kumar, P.P. Synthesis of novel C2 and C2-C8 linked pyrrolo[2,1-c] [1,4]benzodiazepine-naphthalimide hybrids as DNA-binding agents. Bioorg. Med. Chem. Lett., 2003, 13, 3577-3581 (Pubitemid 37141433)
56. Kamal, A.; Ramu, R.; Tekumalla, V.; Khanna, G.B.R.; Barkume, M.S.; Juvekar, A.S.; Zingde, S.M. Remarkable DNA binding affinity and potential anticancer activity of pyrrolo[2,1-c][1,4]benzodiazepine-naphthalimide conjugates linked through piperazine side-armed alkane spacers. Bioorg. Med. Chem., 2008, 16, 7218-7224
57. Kamal, A.; Adil, S.F.; Tamboli, J.R.; Siddardha, B.; Murthy, U.S.N. Synthesis and anticancer activity of phthalimido and naphthalimido substituted dihydropyrimidone conjugates. Lett. Drug Des. Discov., 2008, 5, 261-270
58. Kamal, A.; Adil, S.F.; Tamboli, J.R.; Siddardha, B.; Murthy, U.S.N. Synthesis of coumarin linked naphthalimide conjugates as potential anticancer and antimicrobial agents. Lett. Drug Des. Discov., 2009, 6, 201-209